All Stories

  1. Association of the MAOB rs1799836 Single Nucleotide Polymorphism and APOE ε4 Allele in Alzheimer’s Disease
  2. The Association of Essential Metals with APOE Genotype in Alzheimer’s Disease
  3. Understanding Emotions: Origins and Roles of the Amygdala
  4. Inborn Errors of Metabolism Associated With Autism Spectrum Disorders: Approaches to Intervention
  5. Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview
  6. The Association between TNF-alpha, IL-1 alpha and IL-10 with Alzheimer's Disease
  7. Molecules, Mechanisms, and Disorders of Self-Domestication: Keys for Understanding Emotional and Social Communication from an Evolutionary Perspective
  8. Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue
  9. The Role of Copper in Tau-Related Pathology in Alzheimer’s Disease
  10. PI3K/Akt and ERK1/2 Signalling Are Involved in Quercetin-Mediated Neuroprotection against Copper-Induced Injury
  11. Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain
  12. IL-1β, IL-6, IL-10, and TNFα Single Nucleotide Polymorphisms in Human Influence the Susceptibility to Alzheimer’s Disease Pathology
  13. A non-invasive hidden-goal test for spatial orientation deficit detection in subjects with suspected mild cognitive impairment
  14. Relationships of Cerebrospinal Fluid Alzheimer’s Disease Biomarkers and COMT, DBH, and MAOB Single Nucleotide Polymorphisms
  15. Association of IL-1β, IL-1α and IL-10 single nucleotide polymorphisms with Mini-Mental State Examination and event-related potentials
  16. Rare diseases and omics-driven personalized medicine
  17. IL-1β, IL-6, IL-10, and TNFα single nucleotide polymorphisms are associated with cerebrospinal fluid levels of biomarkers of Alzheimer’s disease
  18. Role of Microglial Cells in Alzheimer’s Disease Tau Propagation
  19. Heines DE. Neuroanatomy Atlas in Clinical Context: Structures, Sections, Systems, and Syndromes10th edition; Baltimore: Wolters Kluwer (Lippincott Williams Wilkins); 2019. 384 pages; ISBN 978-1-975106-68-3, eISBN: 978-1-4963-8416-4
  20. Human neuroblastoma SH-SY5Y cells treated with okadaic acid express phosphorylated high molecular weight tau-immunoreactive protein species
  21. Molecular Mechanisms of Neurodegeneration Related to C9orf72 Hexanucleotide Repeat Expansion
  22. Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease
  23. Hippocampal expression of cell-adhesion glycoprotein neuroplastin is altered in Alzheimer's disease
  24. Event-related Potentials Improve the Efficiency of Cerebrospinal Fluid Biomarkers for Differential Diagnosis of Alzheimer' s Disease
  25. Association of MAPT haplotype-tagging polymorphisms with cerebrospinal fluid biomarkers of Alzheimer's disease: A preliminary study in a Croatian cohort
  26. The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer’s disease
  27. Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia
  28. Using redescription mining to relate clinical and biological characteristics of cognitively impaired and Alzheimer’s disease patients
  29. Coevolution in the timing of GABAergic and pyramidal neuron maturation in primates
  30. Neuroplastin deletion in glutamatergic neurons impairs selective brain functions and calcium regulation: implication for cognitive deterioration
  31. Monoaminergic neuropathology in Alzheimer’s disease
  32. Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer’s Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment
  33. Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies
  34. schizophrenia transcriptomics of the PFC
  35. Stathmin is enriched in the developing corticospinal tract
  36. Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer’s disease
  37. Atomic force microscopy as an advanced tool in neuroscience
  38. Macro- and microarchitecture of cognitive processing
  39. Ceramides in Alzheimer’s Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and AβAccumulation
  40. Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
  41. In search of the definitive Brodmann's map of cortical areas in human
  42. Early Failure of the Default-Mode Network and the Pathogenesis of Alzheimer's Disease
  43. Congenital brain anomalies and chromosomal aberrations from the Zagreb Collection of human brains
  44. CSF tau protein phosphorylated at threonine 231 as a potential biomarker of early-stage Alzheimer's disease
  45. Genotype-independent decrease in plasma dopamine beta-hydroxylase activity in Alzheimer's disease
  46. Pathogenesis, modulation, and therapy of Alzheimer’s disease: A perspective on roles of liver-X receptors
  47. Comparison of two commercial enzyme-linked immunosorbent assays for cerebrospinal fluid measurement of amyloid β1–42 and total tau
  48. Hyperphosphorylation of tau by GSK-3β in Alzheimer’s disease: The interaction of Aβ and sphingolipid mediators as a therapeutic target
  49. Functional reorganization oF the primary motor cortex in a patient with a large arteriovenous malFormation involving the precentral gyrus
  50. Human fetal tau protein isoform: Possibilities for Alzheimer's disease treatment
  51. fMRI neural activation patterns induced by professional military training
  52. The Reliability and Validity of the Mini-Mental State Examination in the Elderly Croatian Population
  53. Extraordinary neoteny of synaptic spines in the human prefrontal cortex
  54. Comparative analysis of the nucleus basalis of Meynert among primates
  55. The Zagreb Collection of human brains: a unique, versatile, but underexploited resource for the neuroscience community
  56. Recent developments in neuropathology of autism spectrum disorders
  57. HSV1 in Alzheimer’s disease: Myth or reality?
  58. Giant cavernoma of the skull and skeletal-extraskeletal angiomatosis associated with paraproteinemia
  59. Recent advances in the neurobiology of attachment behavior
  60. Treatment strategies for spinal muscular atrophy
  61. Astrocyte expression of D2-like dopamine receptors in the prefrontal cortex
  62. CSF tau proteins in differential diagnosis of dementia
  63. Message from the Editors-in-Chief
  64. Does Alzheimer's disease begin in the brainstem?
  65. Pathogenesis of proximal autosomal recessive spinal muscular atrophy
  66. Abnormal motoneuron migration, differentiation, and axon outgrowth in spinal muscular atrophy
  67. Endosomal location of dopamine receptors in neuronal cell cytoplasm
  68. Nucleus subputaminalis: neglected part of the basal nucleus of Meynert
  69. Hemispheric asymmetry, modular variability and age-related changes in the human entorhinal cortex
  70. Phosphorylation Pattern of tau Associated with Distinct Changes of the Growth Cone Cytoskeleton
  71. Pathological tau proteins in argyrophilic grain disease
  72. nNOS Expression in Reactive Astrocytes Correlates with Increased Cell Death Related DNA Damage in the Hippocampus and Entorhinal Cortex in Alzheimer's Disease
  73. Ultrastructural Analysis and TUNEL Demonstrate Motor Neuron Apoptosis in Werdnig-Hoffmann Disease
  74. Nucleus subputaminalis (ayala): the still disregarded magnocellular component of the basal forebrain may be human specific and connected with the cortical speech area
  75. Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease
  76. Ontogenesis of goal-directed behavior: anatomo-functional considerations